Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Lung Diseases 1

Interventions

Carboplatin 5 Cisplatin 3 zipalertinib 2 Pemetrexed 2 Paclitaxel 2 Nivolumab 2 Blood Specimen Collection 2 zimberelimab 1 selpercatinib 1 sacituzumab govitecan 1 repotrectinib 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 alectinib 1 Toll-Like Receptor 1 1 Surveys and Questionnaires 1 One-Lung Ventilation 1 Ipilimumab 1 Health Records, Personal 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Diseases × One-Lung Ventilation × 90 days × Clear all

NCT00534690 2026-05-15

REVOLU

University Hospital, Bordeaux

Phase NA Completed

Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡